19 Stanwell Road Penarth
Cardiff CF64 2EZ
Industry: Diagnostics & Research
Full Time Employees:
|Mr. James R. McCullough||CEO & Director||N/A||N/A||1968|
|Mr. Thomas H. McLain||Pres & Chief Commercial Officer||N/A||N/A||1959|
|Mr. Oliver James Sterling III||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Sally Bowden||Chief Operating Officer||N/A||N/A||N/A|
|Fergus Fleming||CTO & Director||N/A||N/A||N/A|
Renalytix AI plc develops artificial intelligence (AI) enabled clinical decision support solutions for kidney disease. It is developing KidneyIntelX, an AI-enabled, clinical-laboratory based solution that supports physician decision making by improving identification, prediction, and risk stratification of patients with kidney disease. The company is based in Cardiff, the United Kingdom. Renalytix AI plc (AIM:RENX) operates independently of EKF Diagnostics Holdings plc as of November 2, 2018.
Renalytix AI plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.